Jane Street Group, LLC Precigen, Inc. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 15, 2022	SELL	$3.53 - $5.5 $141,200 - $220,000	-40,000 Reduced 56.66%	30,600 $114,000
Q3 2021 Nov 16, 2021	SELL	$4.99 - $6.55 $135,728 - $178,160	-27,200 Reduced 27.81%	70,600 $352,000
Q2 2021 Aug 16, 2021	SELL	$6.24 - $8.22 $26,832 - $35,346	-4,300 Reduced 4.21%	97,800 $638,000
Q1 2021 May 18, 2021	BUY	$6.74 - $10.95 $195,460 - $317,550	29,000 Added 39.67%	102,100 $703,000
Q4 2020 Feb 17, 2021	BUY	$3.75 - $10.56 $142,875 - $402,336	38,100 Added 108.86%	73,100 $746,000
Q2 2020 Aug 17, 2020	BUY	$2.16 - $5.46 $75,600 - $191,100	35,000 New	35,000 $175,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $156M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.